HAEMOPHILUS INFLUENZAE TYPE-C BRONCHOPNEUMONIA.
LOWE MB.
J Pathol Bacteriol. 1964 Jul;88:315-6. doi: 10.1002/path.1700880142.
Associated Bacterial Coinfections in COVID-19-Positive Patients.
Boia ER, Huț AR, Roi A, Luca RE, Munteanu IR, Roi CI, Riviș M, Boia S, Duse AO, Vulcănescu DD, Horhat FG.
Medicina (Kaunas). 2023 Oct 19;59(10):1858. doi: 10.3390/medicina59101858.
Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.
Miyazaki S, Fujikawa T, Matsumoto T, Tateda K, Yamaguchi K.
J Antimicrob Chemother. 2001 Sep;48(3):425-30. doi: 10.1093/jac/48.3.425.
Nontypeable Haemophilus influenzae in the elderly.
Berk SL, Holtsclaw SA, Wiener SL, Smith JK.
Arch Intern Med. 1982 Mar;142(3):537-9.
Neonatal Haemophilus influenzae infections.
al-Mofada SM.
J Infect. 1994 Nov;29(3):283-7. doi: 10.1016/s0163-4453(94)91174-6.
Haemophilus influenzae type b pneumonia.
Wald ER, Levine MM.
Arch Dis Child. 1978 Apr;53(4):316-8. doi: 10.1136/adc.53.4.316.
New murine model of bronchopneumonia due to cell-bound Haemophilus influenzae.
Miyazaki S, Nunoya T, Matsumoto T, Tateda K, Yamaguchi K.
J Infect Dis. 1997 Jan;175(1):205-9. doi: 10.1093/infdis/175.1.205.
Non-typeable Haemophilus influenzae purulent pericarditis in a child with cystic fibrosis.
Downes KJ, Abulebda K, Siracusa C, Moore R, Staat MA, Poynter SE.
Pediatr Int. 2016 Jul;58(7):607-9. doi: 10.1111/ped.12850. Epub 2016 Feb 4.
Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
Bragonzi A.
Int J Med Microbiol. 2010 Dec;300(8):584-93. doi: 10.1016/j.ijmm.2010.08.012. Epub 2010 Oct 14.
Clinical efficacy of carumonam.
Drabu YJ, Mehtar S, Blakemore PH.
Drugs Exp Clin Res. 1988;14(10):665-7.
